Ojemda 100 mg, Filmtabletten

7680702600031 CH-70260 Filmtabletten

No image available

Article details

Package size
24
Selling units
24
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/06/2026
Patient information leaflet
Français
13/06/2026
Patient information leaflet
Italien
13/06/2026

Detailed composition

Substance Quantity Type Category
tovorafenibum
100.0 MG Substance Wirkstoff (Principe actif)
copovidonum K 28
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrium
- Substance HBESI
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 8000
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK

Authorization holder

IPSEN Pharma Schweiz GmbH

6300 Zug

Authorization information

Swissmedic authorization number
70260
Drug name
Ojemda, Filmtabletten
Galenic form
FILM
ATC Code
L01EC04
Authorization status
B
Dispensing category
A
First authorization
05/05/2026
Authorization expiration date
05/05/2028
IT Number
07.16.1.
Domain
Human medicine
Field of application
Pädiatrisches niedriggradiges Gliom mit BRAF‑Fusion, ‑Rearrangement oder BRAF‑V600‑Mutation nach vorangegangener systemischer Therapie.

Package details

Description (FR)
OJEMDA cpr pellic 100 mg 24 pce
Description (DE)
OJEMDA Filmtabl 100 mg 24 Stk
Market launch
01/07/2026
Narcotic (BTM)
No

Other package sizes (2)

OJEMDA cpr pellic 100 mg 16 pce
16 TABL
GTIN: 7680702600017
View
OJEMDA cpr pellic 100 mg 20 pce
20 TABL
GTIN: 7680702600024
View
Buy us a coffee Explore the data